NEW STUDY: BIG PHARMA’S BIOLOGIC PATENT ABUSE WILL COST AMERICAN PATIENTS AN ADDITIONAL $25 BILLION WITHOUT REFORM

09-22-2020 Press Release

Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold Drug Companies Accountable Would Lower Prices And Increase Innovation For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a new study from Avik Roy and Gregg Girvan of the Foundation […]

CSRXP: PRESIDENT SHOULD FOCUS ON HOLDING BIG PHARMA ACCOUNTABLE TO LOWER RX PRICES, ABANDON REBATE RULE

09-13-2020 Press Release

Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Drug Prices, While Increasing Medicare Premiums For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Sunday in response to tweet chain from the president announcing he signed an executive order tying drug prices […]

CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices

09-1-2020 Press Release

U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of Blockbuster Cancer, Immunosuppressant Drugs Will Help Hold Industry Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to news that the U.S. House Oversight Committee will subpoena Big […]

BIG PHARMA DOUBLES DOWN ON SUMMER PRICE HIKES AS AMERICANS CONTINUE TO BATTLE PANDEMIC

08-27-2020 Press Release

Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name Drugs This Summer Despite Economic Crisis and Rising Concern With Rx Affordability For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on updated data showing Big Pharma continued hiking […]

CSRXP: BIG PHARMA’S COUNTEROFFER TO WHITE HOUSE WOULD HURT AMERICAN SENIORS & DO NOTHING TO LOWER DRUG PRICES

08-26-2020 Press Release

White House Should Reject Pharma-Backed Policies That Would Hand Drug Companies a Windfall on the Backs of American Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday in response to two alternative drug pricing proposals to Medicare Parts B and D […]

CSRXP LAUNCHES TELEVISION AND DIGITAL AD CAMPAIGN AGAINST REBATE RULE, AKA BIG PHARMA BAILOUT

08-4-2020 Press Release

Encourages Administration to Reject Measure That Would Increase Premiums on Medicare Part D Beneficiaries, Cost Taxpayers Billions and Boost Profits for Drug Companies For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched a television and digital advertising campaign Tuesday against the proposed Rebate Rule in […]

CSRXP: WHITE HOUSE MUST STAND UP TO BIG PHARMA AND HOLD INDUSTRY ACCOUNTABLE FOR PRICE HIKES

07-27-2020 Press Release

Administration Should Withdraw Big Pharma-Backed Policies Like the Rebate Rule, Move Forward with Solutions to Stop Drug Companies’ Price Gouging For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Monday after Big Pharma scuttled a scheduled meeting on prescription drug prices between White […]

REBATE RULE A BIG PHARMA BAILOUT PAID FOR ON THE BACKS OF AMERICAN SENIORS AND TAXPAYERS

07-24-2020 Press Release

Administration Should Abandon Previously Rejected Measure That Rewards Drug Companies’ Pandemic Price Hikes and 340B Changes That Would Undermine Critical Program for Many of America’s Most Vulnerable   For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday after the President signed […]

THEY SAID IT: GOP AND CONSERVATIVE LEADERS CONCERNED WITH NEGATIVE IMPACT OF REBATE RULE

07-22-2020 Blog PostsPress Release

HHS Secretary, Republican Lawmakers, Right-of-Center Policy Experts and Conservative Commentators Raised Doubts on Premium Increases, Cost to Taxpayers and Bailout for Big Pharma Reports this week indicate the administration may reboot a policy known as the Rebate Rule. The Rebate Rule was previously withdrawn by the White House amid concerns, on both sides of the […]

BIG PHARMA EARNINGS WATCH: NOVARTIS

07-22-2020 Blog PostsPress Release

Brand Name Drug Company Beats Earnings Forecasts After Repeatedly Hiking Prices New earnings reports for the second quarter of 2020 show that Big Pharma giants are continuing to rake in profits while hiking prescription drug prices. On Tuesday, Big Pharma drug company Novartis announced it bested earnings forecasts for the second quarter after hiking prices […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.